MD Anderson Cancer Center at the University of Texas is today launching the Moon Shots Program, “an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.” The program is backed by billions of dollars in funding, and there is some controversy around the money and the science. The program will initially target eight cancers, and will bring together sizable multidisciplinary groups of MD Anderson researchers and clinicians to mount comprehensive attacks on acute myeloid leukemia/myelodysplastic syndrome; chronic lymphocytic leukemia; melanoma; lung cancer; prostate cancer, and triple-negative breast and ovarian cancers – two cancers linked at the molecular level.